Latest Whitepapers

Droplet Digital PCR (ddPCR) is a refined form of digital PCR that offers a scalable and practical method for the absolute quantification of nucleic acids. 2021 marks ten years since the advent of ddPCR and in that time it has revolutionized discovery, development and quality control of biopharmaceuticals such as antibody-based biologics, vaccines, and cell and gene therapies.

Download this whitepaper to uncover predicting disease onset via clinical biomarkers as well as other potential applications in diabetes research.

Over the last decade, the number of clinical trials involving recombinant adeno-associated viral (AAV) vectors has dramatically increased, the diversity of serotypes has expanded and the demand for larger quantities of highly purified material manufactured to cGMP standards has rocketed.

Download this whitepaper to discover how a contract development manufacturing organization was able to establish an AAV production platform and much more.

The efficiency of candidate antibody discovery pipelines is directly connected to the quality of the DNA library being screened. To reduce discovery timelines, researchers need access to tools allowing them to take more shots on goal, as well as line up these shots effectively.

With recent advances in cancer detection and prevention, a future where cancer can be cured is starting to feel within reach. One significant area of progress is early detection, which can go a long way toward eliminating cancer.

Download this whitepaper to discover how to overcome the limitations of PCR testing, how RT-qPCR will impact diagnostics both in lab and at point of care and how RT-qPCR is driving new methods and applications.

Download this whitepaper to learn more about mRNA therapeutics including how they could treat genetic diseases and cancer, the challenges associated with delivery and dosage as well as how to avoid an unwanted immune response.

In this cell and gene therapy insights expert roundtable, a panel of four experts will answer some central questions surrounding the development of novel biotherapeutics.

The quality of indoor air dramatically affects the health of animals and humans during livestock production. Airborne transmission has been suspected of being responsible for epidemics of highly infectious diseases in livestock production, and due to the COVID-19 pandemic, there has been increasing concern about the role of wild animals in the epidemiology of most zoonoses.